Terumo Interventional Systems (TIS) has reported the first clinical use of its Opuswave Dual Sensor Imaging System in the US.
The procedure took place at the Mount Sinai Fuster Heart Hospital in New York, led by Annapoorna Kini.
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The Opuswave system is built around the DualView Imaging Catheter, which brings together optical frequency domain imaging (OFDI) and intravascular ultrasound (IVUS) within a single platform.
This capability is designed to produce complementary, simultaneous views of the coronary anatomy, allowing for a broader assessment during coronary interventions.
Terumo states that the device addresses the long-standing need to combine the deep vessel visualisation offered by IVUS with the high-resolution surface imaging possible with OFDI.
Terumo Medical Corporation chief medical officer Michael Martinelli said: “In the past, interventional cardiologists have had to choose between two different imaging approaches.
“The Opuswave Imaging System eliminates that trade-off by providing both IVUS and OFDI imaging in a single catheter, providing the physician the opportunity to leverage the strengths of each modality simultaneously.
“This provides the physician with increased clarity and insight for more informed decision-making in real time, leading to greater confidence when treating the individual patient.”
The DualView catheter features a 2.6 French scale (Fr) profile, 6 Fr guide compatibility and a hydrophilic coating intended to enhance deliverability.
It also offers a 150mm pullback capability for both imaging modalities, enabling what Terumo describes as the longest single-run pullback length available.
The system supports IVUS-only, OFDI-only or combined dual imaging modes. This range of options allows physicians to adapt imaging to specific clinical scenarios.
TIS offers products for coronary, peripheral and endovascular treatments. Its stated areas of focus include transradial access, complex coronary interventions, peripheral artery disease and embolotherapy.
